IPO Date: Jun 18 to Jun 20 2025
Listing Date: Jun 25 2025
1. Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division.
2. Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division.
3. Purchase of Machineries for Homecare and Cosmetic Division.
4. General Corporate Purposes.
109, Ghanshyam Enclave Premises Co- Op Soc Plot No. 856 Laljipada, Kandivali (West)
Mumbai
Maharashtra
400067
7045997809
cs@influxhealthtceh.com
www.influxhealthtech.com
Maashitla Securities Pvt Ltd.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, L&T Technology Services has informed that L&T Technology Services (‘LTTS’) has secured a landmark engagement valued at over $75 Million from a leading global technology enterprise. As part of the 5-year agreement, LTTS will deploy its Engineering Intelligence (‘EI’) capabilities across the end-to-end product development and engineering lifecycle, helping accelerate the development of next generation solutions for the customer’s global portfolio. LTTS will also enable the creation of a dedicated Engineering Center for technology and digital functions, leveraging its full stack of EI solutions. The above information was received by the Company Secretary & Compliance Officer on August 18, 2026 at around 7:20 PM (IST). With respect to above, information pursuant to SEBI Master Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026, is appended as Annexure A.
The above information is a part of company’s filings submitted to BSE.
According to the data released by the NSE, the Foreign Institutional Investors (FIIs) were net sellers of Rs 26192.08 crore in index futures and options segments, as per Tuesday’s data, August 18, 2026.
FIIs were net sellers of index futures to the tune of Rs 2029.03 crore and net sellers of index options worth Rs 24163.05 crore. In the stock segment, FII’s were net sellers of stock futures worth Rs 1753.00 crore and they sold stock options worth Rs 1141.29 crore.
Futures & Options (F&O) total turnover stood at 4,44,26,474.93 crore on August 18 and the total number of contracts traded on the day were 28,61,88,319.
Of the total turnover, Index Futures contributed Rs 10,287.56 crore, Stock Futures Rs 73,165.16 crore and Index Options Rs 4,37,68,093.85 crore, while the contribution of the Stock Options was of Rs 5,74,928.36 crore.
For the day, the total F&O Put Call ratio stood at 0.99, while the Index Options Put Call ratio was 1.01 and that of Stock Options was 0.49.
With an aim to expand bilateral ties, the Ministry of External Affairs (MEA) has said the fourth round of the India-Singapore Ministerial Roundtable (ISMR) will be held in Singapore on August 20, 2026, with the two countries looking to further expand cooperation in key sectors such as trade, investment, advanced manufacturing and digitalization. External Affairs Minister S Jaishankar, Commerce Minister Piyush Goyal, Finance Minister Nirmala Sitharaman and Minister of State for Electronics and Information Technology Jitin Prasada will travel to Singapore to attend the ISMR. During their visit, the ministers will meet their counterparts and call on the Singaporean leadership.
The MEA said the ISMR is an important platform for driving cooperation, including in new and emerging areas. Its inaugural meeting was held in New Delhi in September 2022, followed by the second meeting in Singapore in August 2024 and the third in New Delhi in August 2025. Deliberations on advanced manufacturing, connectivity, digitalization, healthcare and medicine, skills development and sustainability at these meetings have helped shape the Roadmap for the India-Singapore Comprehensive Strategic Partnership (CSP). The CSP Roadmap was unveiled during Singapore Prime Minister Lawrence Wong's visit to India in September 2025.
Singapore is India's largest trading partner in ASEAN (Association of Southeast Asian Nations). It is also India's leading source of foreign direct investment (FDI) and among the largest sources of external commercial borrowings and foreign portfolio investment. Singapore was India's sixth-largest trading partner in the financial year 2024-25. India's imports from Singapore stood at $21.2 billion in 2024-25, while exports to the country were valued at $14.4 billion. Over the past 10 years, Singapore's annual investments in India have ranged between $10 billion and $15 billion.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 0.40 | 375.11 | -99.89 | 0.40 | 375.11 | -99.89 | 1251.44 | 853.23 | 46.67 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.31 | 0.24 | 5862.50 |
| PBIDT | -2.11 | 0.84 | -351.19 | -2.11 | 0.84 | -351.19 | 3.77 | 22.97 | -83.59 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.68 | 1.52 | 10.53 |
| PBDT | -2.11 | 0.84 | -351.19 | -2.11 | 0.84 | -351.19 | 2.09 | 21.45 | -90.26 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| PBT | -2.11 | 0.84 | -351.19 | -2.11 | 0.84 | -351.19 | 2.08 | 21.44 | -90.30 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -2.11 | 0.84 | -351.19 | -2.11 | 0.84 | -351.19 | 1.95 | 21.44 | -90.90 |
| Equity | 87.50 | 87.50 | 0.00 | 87.50 | 87.50 | 0.00 | 87.50 | 87.50 | 0.00 |
| PBIDTM(%) | -527.50 | 0.22 | -235696.25 | -527.50 | 0.22 | -235696.25 | 0.30 | 2.69 | -88.81 |
No Records Found
The issue size of Influx Healthtech Ltd. IPO is ₹39.72 - 41.90 crore.
The Influx Healthtech Ltd. IPO opens for subscription on 2025-06-18 and closes on 2025-06-20.
The price range of Influx Healthtech Ltd. IPO is ₹91.00 to ₹96.00.
The lot size of Influx Healthtech Ltd. IPO is 1200 shares.
The registrar of Influx Healthtech Ltd. IPO is Maashitla Securities Pvt Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.